NOV

7.89%

4.1¢ novatti group limited

Hi dubspec, could you please help us to ask these questions in...

First 76 Last

Share
Profile

Follow
Longtermasx

119 Posts.

12

25/08/22

17:53

Post #: 63326545
Share

Originally posted by CyberViber: ↑

I'd like to suggest, if possible, to jump into the annual report webinar when it becomes known... and throw some of these curly questions to the host. You will get much more relevant and true representation from dealing directly with management. They will be able to give you facts instead of opinion and speculation. Cheers

Expand

Originally posted by dubspec: ↑

hey guys. thought id lrt you know my thoughts about point 1. moreso pros cons of own license. again this is just yo help you understabd the market for Merchant Acquiring (shortened to 'acquiring' which is the acceptance of payments (ie, cards).

getting osn license

PROS
- no need to rely on 3rd parties, who in theory, could cut the relationship and leave you in a pickle.
- you own the client outright
- with economies of scale and robust operations (not over spending on ops) will provide cost advantages

CONS
- there are costs. compliance, licensing, billing engines, serving staff, tech, etc. putting capital in means you need a return on that capital. it means you need to really have a decent book of volume/clients to make ot worth while. these costs are not psid by an ISO.

**it really all comes down to cost. considerations are**
- what are the fixed costs to maintain the license.
- what cost are involved in improving capabilities to ensure you stay competitive
- what are the marginal costs of adding volume/clients into Nov? what is the marginal cost having the license vs tapping of soneone else's license.

owning the client is also a consideration. For instance, as an ISO you dont contract the cluent so don't own the contract. You only own the relationship. some acquirers will try and contract ISO that they can't take the volume from that acquirer if you want yo move to another acquirer - this means you are in a way stuck with that acquirer.

as a TPP (like ISO but own branding, billing, servicing, contacts, etc) there is way more freedom than an ISO but you arent respinsivle for maintaing the license and tech that runs the license (the acquiring engine/switch).

let me know if you have any questions.

i was also approached yesterdsy by a European company to integrate crypto payments into my gateway. im a small gateway (but nimble in tech)and was targeted so no doubt a lot of other gateways are thinking of it or have been approached. So imo its really important to understand NOVs ETA for only crypto in their gateway. If NOV had a big book already it wouldnt matter as much but it seems NOV is selling the crypto as the competitive advantage yet in 6-12 months that advantage may be gone.

let me know if you have any questions

ps: my fat fingers and mistyping is just part of my package - please forgive me

Expand

Hi dubspec, could you please help us to ask these questions in the webinar since you are the expert?

Many thanks

NOV Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

RCE

Recce's R327 found effective against E.coli during clinical trial

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

There are more pages in this discussion • 2 more messages in this thread...

First 76 Last

Add NOV (ASX) to my watchlist

(20min delay)
Last 4.1¢		Change 0.003(7.89%)		Mkt cap ! $14.58M

Open	High	Low	Value	Volume
3.9¢	4.1¢	3.9¢	$5.7K	143.6K

Buyers (Bids)

No.	Vol.	Price($)
1	24799	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	74239	2

View Market Depth

No.	Vol.	Price($)
1	24799	0.039
1	100000	0.038
2	57437	0.037
1	100000	0.036
2	425000	0.035

Price($)	Vol.	No.
0.041	74239	2
0.042	45919	2
0.043	20000	1
0.044	29233	2
0.045	31954	3

Last trade - 16.10pm 28/06/2024 (20 minute delay)

NOV (ASX) Chart

Hi dubspec, could you please help us to ask these questions in...

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi dubspec, could you please help us to ask these questions in...

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News